fewer orders for Onglyza and other "gliptins" for treating type 2 diabetes

You might see fewer orders for Onglyza and other "gliptins" for treating type 2 diabetes.

Gliptins are popular because they're taken orally once a day...and rarely cause hypoglycemia or weight gain.

But they don't lower blood sugar that much...and there are concerns about possible pancreatitis and heart failure.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote